Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Combining corticosteroids and non-ablative fractional laser therapy may effectively treat extensive alopecia areata.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Current methods can't fully recreate skin and its features, and more research is needed for clinical use.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Dermoscopy helped diagnose a rare skin disease which slightly improved with treatment.

New technique implants pigment in scalp with less pain and damage.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Balding people may have higher heart disease risk.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

A man with rare skin changes on his fingers was diagnosed with multiple myeloma-linked amyloidosis.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

The document reviews key historical figures and discoveries in dermatology.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

More research is needed to understand the long-term benefits of insulin-sensitizing drugs for treating adolescents with PCOS.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.